Escientia Life Sciences

Escientia Life Sciences is a global Contract Development and Manufacturing Organization (CDMO) specializing in the discovery, development, and commercialization of small molecule drugs and complex Active Pharmaceutical Ingredients (APIs). Founded by former pharmaceutical executives from major firms like Bristol-Myers Squibb, the company provides end-to-end services including process R&D, medicinal chemistry, and large-scale GMP manufacturing. The company operates with a hybrid model, maintaining R&D centers in Connecticut, USA, and Hyderabad, India, alongside a state-of-the-art manufacturing facility in Visakhapatnam, India. Escientia is recognized for its expertise in solving complex synthetic chemistry challenges and developing novel, patentable routes for drug production that emphasize green chemistry and cost-efficiency. In 2020, the company was acquired by Deccan Fine Chemicals, further integrating its operations into a global chemical manufacturing network.